Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial
about
Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptivesOffering extended use of the combined contraceptive pill: a survey of specialist family planning servicesExtended regimen combined oral contraception: A review of evolving concepts and acceptance by women and cliniciansClinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptivesContraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling.Susceptibility to nausea and motion sickness as a function of the menstrual cycle.Characteristics of scheduled bleeding manipulation with combined hormonal contraception in university students.Extended- and continuous-cycle oral contraceptives.Continuous use of oral contraceptives: an overview of effects and side-effects.Extended and continuous combined contraceptive regimens for menstrual suppression.Hormone withdrawal-associated symptoms: overlooked and under-explored.Evolution of extended use of the combined oral contraceptive pill.Association between oral contraceptive use and markers of iron deficiency in a cross-sectional study of Tanzanian women.Evaluating the physiological and behavioral response of a male and female gorilla (Gorilla gorilla gorilla) during an introduction.The 'nonmenstrual woman' in the new millennium? Discourses on menstrual suppression in the first decade of extended cycle oral contraception use in Canada.A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
P2860
Q28265684-394CE776-BCBF-4232-AA83-A69B39AE6E70Q28389530-7F1DF839-ABF6-4E4F-8CFD-2D3B0529C135Q28392784-5FE9AEBD-4DA8-4EB8-8F0C-2BFB2B07F8DFQ33765400-45C1FA93-7827-41E1-B882-38FA90DECEE1Q35688513-6A37ABA2-FFCC-4313-B9BB-F30E3E868625Q36851655-2B2B4330-7282-47D0-A007-C50BA38FE449Q37100852-B24EFC21-7AF3-4406-A05A-8E06E5B4C06DQ37227517-55E99258-EE66-4287-9944-B8860AB469E3Q38053497-805B9C05-87EC-495F-B757-C17058A3C0E1Q38065342-B5FC10DD-B069-496B-96C9-704F8C7906E7Q38082793-A82E3155-EB4B-475B-A8F6-53C4CE7037FAQ38197591-4FD4BDED-9FBD-4234-9D51-AF22C3D7DB24Q40443031-BA339D99-98E3-4CA4-B006-6A2EE265514BQ46864229-98898754-1840-4DF9-952C-70CDB2CA55AEQ48079737-12E719BE-8377-4CC7-9262-7B1C41C72313Q53658082-357B79AC-A29A-4D4E-874D-8856AF413659
P2860
Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Long-term safety of an extende ...... ter open-label extension trial
@ast
Long-term safety of an extende ...... ter open-label extension trial
@en
Long-term safety of an extende ...... ter open-label extension trial
@nl
type
label
Long-term safety of an extende ...... ter open-label extension trial
@ast
Long-term safety of an extende ...... ter open-label extension trial
@en
Long-term safety of an extende ...... ter open-label extension trial
@nl
prefLabel
Long-term safety of an extende ...... ter open-label extension trial
@ast
Long-term safety of an extende ...... ter open-label extension trial
@en
Long-term safety of an extende ...... ter open-label extension trial
@nl
P2093
P1476
Long-term safety of an extende ...... ter open-label extension trial
@en
P2093
David Portman
F D Anderson
William Gibbons
P356
10.1016/J.AJOG.2005.12.045
P407
P577
2006-07-01T00:00:00Z